FDA lifts Gambro U.S. import alert Gambro has successfully addressed the observations cited in the U.S. Food and Drug Administration's (FDA) January 2006 warning letter to the company's monitor manufacturing facilities in Dasco, Italy and Lund, Sweden. As a result the FDA has lifted the Import Alert preventing the import of Gambro's Phoenix® and Prismaflex® machines into the United States. For further information www.gambro.com EQT media contact Johan Hähnel, Director, Communications & PR Phone: +46 8 506 55 322 Mobile phone: +46 70 605 6334 www.eqt.se Investor IR and media contact Fredrik Lindgren, Head of Corporate Communications Tel: +46 8 614 2031 Mobile phone: +46 735 24 2031 www.investorab.com Our press releases can be accessed at www.investorab.com on the Internet. Investor is the largest industrial holding company in the Nordic region. For almost a century, our business concept has been generate attractive long-term returns by investing in companies with solid potential for value creation and applying our experience, knowledge and network to make them best-in-class. Investor is a leading shareholder in a number of multinational companies, including SEB, ABB and Ericsson. Investor also conducts private equity activities in the United States, Northern Europe and Asia.
FDA lifts Gambro U.S. import alert
| Source: Investor AB
Attachments
